MedTrace Logo

Sputum Cytology in Screening Heavy Smokers For Lung Cancer

NCT00103363 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 3270

Last updated 2014-05-07

No results posted yet for this study

Summary

RATIONALE: Screening tests, such as sputum cytology, may help doctors find tumor cells early and plan better treatment for lung cancer.

PURPOSE: This phase II trial is studying how well sputum cytology works in screening heavy smokers for lung cancer.

Conditions

Interventions

OTHER

cytology specimen collection procedure

OTHER

physiologic testing

PROCEDURE

annual screening

PROCEDURE

study of high risk factors

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Timothy Kennedy · University of Colorado, Denver

Study Design

Purpose
SCREENING

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-02-28
Primary Completion
1994-02-28
Completion
1994-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00103363 on ClinicalTrials.gov